Disruption of gut barrier integrity and host–microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus R Forlano, L Martinez-Gili, P Takis, J Miguens-Blanco, T Liu, ... Gut microbes 16 (1), 2304157, 2024 | 5 | 2024 |
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data F Soltani, DA Jenkins, A Kaura, J Bradley, N Black, JP Farrant, ... BMC cardiovascular disorders 24 (1), 343, 2024 | | 2024 |
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement BP Lee, K Witkiewitz, J Mellinger, FA Anania, R Bataller, TG Cotter, ... Nature Reviews Gastroenterology & Hepatology, 1-20, 2024 | 1 | 2024 |
P340 Multi-tissue profiling of oxylipins reveals epoxide: diol ratio up-regulation that associates with white adipose tissue inflammation and liver steatosis in obesity C Hateley, A Olona, L Halliday, M Edin, JH Ko, R Forlano, X Terra, ... Gut 73 (Suppl 1), A258-A258, 2024 | | 2024 |
FRI-431 The underestimated burden of hepatitis D among people living with chronic hepatitis B in the Gambia EV Quang, P Ingiliz, A Ceesay, I Chemin, S Drammeh, S Chevaliez, ... Journal of Hepatology 80, S786-S787, 2024 | | 2024 |
FRI-418 10-year clinical outcomes in chronic hepatitis B patients treated with tenofovir in The Gambia, West Africa EV Quang, G Ndow, S Bah, R Bangura, L Bojang, B Dibba, S Drammeh, ... Journal of Hepatology 80, S782, 2024 | | 2024 |
THU-247-YI Multi-tissue profiling of oxylipins reveal a conserved upregulation of epoxide: diol ratio that associates with white adipose tissue inflammation and liver steatosis … C Hateley, A Olona, L Halliday, M Edin, JH Ko, R Forlano, X Terra, F Lih, ... Journal of Hepatology 80, S580-S581, 2024 | | 2024 |
WED-546 Evidence of gut microbiome differences in post-menopausal females with metabolic dysfunction-associated liver disease compared to pre-menopausal females and males L Martinez-Gili, R Forlano, JM Blanco, P Takis, MR Thursz, JR Marchesi, ... Journal of Hepatology 80, S282-S283, 2024 | | 2024 |
FRI-286 Muscle function and walking time are associated with better quality of life in MASLD patients R Forlano, T Kirupakaran, M Couffon, B Martino, G Sigon, J Huang, ... Journal of Hepatology 80, S495, 2024 | | 2024 |
THU-326 Improvement in alcohol-associated hepatitis is characterized by reduction of RNA modification processes AM Kilpatrick, DR Torres, S Atkinson, LD Tyson, N Vergis, MR Thursz, ... Journal of Hepatology 80, S130, 2024 | | 2024 |
Exploring the immunomodulatory potential of TLR7/8 agonism in decompensated cirrhosis D Patseas, R Sheth, WY Lee, G Hagger, E Mitchell, FM Trovato, ... | | 2024 |
THU-317 Alcohol-related hepatitis is associated with a distinctive pattern of disordered bile acid metabolism and reduced bile acid transporter expression LD Tyson, SR Atkinson, BH Mullish, A Pechlivanis, M Allison, A Austin, ... Journal of Hepatology 80, S127, 2024 | | 2024 |
TOP-553 Deciphering the immunological dynamics of flares following nucleos (t) ide analogue (NA) cessation in HBeAg negative chronic hepatitis B in a large, longitudinal, phase … S Phillips, S Mistry, N Harris, D Zope, C Moore, G Hahn, M Rosario, ... Journal of Hepatology 80, S350, 2024 | | 2024 |
SAT-274 Serum proteomic analyses reveal elevated HGFand IL-8 in patients with alcohol-related hepatitis compared to decompensated alcohol-related cirrhosis and can … LD Tyson, SR Atkinson, VC Patel, M Allison, A Austin, JW Dear, ... Journal of Hepatology 80, S145, 2024 | | 2024 |
FRI-215-YI MASL-B registry: results from a european cohort of patients with chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease R Forlano, L Martinez-Gili, M Lacey, G Sigon, BH Mullish, V Mallet, ... Journal of Hepatology 80, S470, 2024 | | 2024 |
LBO-003 Results of a phase 2b multicenter randomized trial of larsucosterol for the treatment of severe alcohol-associated hepatitis (AHFIRM trial) M Shiffman, B Da, L Stein, C Moreno, A Mehta, A Louvet, A Nicoll, A Goel, ... Journal of Hepatology 80, S8-S9, 2024 | | 2024 |
OS-008-YI Cellular senescence is reduced following alcohol cessation in severe alcohol-associated hepatitis D Rodrigo-Torres, AF Kilpatrick, SR Atkinson, S Ferreira-Gonzalez, ... Journal of Hepatology 80, S14, 2024 | | 2024 |
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry TH Schwantes-An, JB Whitfield, GP Aithal, SR Atkinson, R Bataller, ... Hepatology Communications 8 (6), e0431, 2024 | 1 | 2024 |
Healthcare interactions prior to first hospital admission with alcohol‐related liver disease H Lewis, R Parker, Z Ul‐Haq, A Lucas, C Cohen, N Vergis, M Thursz Liver International, 2024 | | 2024 |
Multi-tissue profiling of oxylipins reveal a conserved up-regulation of epoxide: diol ratio that associates with white adipose tissue inflammation and liver steatosis in obesity C Hateley, A Olona, L Halliday, ML Edin, JH Ko, R Forlano, X Terra, ... Ebiomedicine 103, 2024 | | 2024 |